What does this research mean for the field?

A self-assembled nanoplatform combining a Src kinase inhibitor and a near-infrared phototherapeutic agent synergistically suppresses gastric cancer through photothermal ablation and blockade of Src-mediated angiogenesis and proliferation pathways. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to develop a nanoplatform that synergistically combines anti-angiogenic and photothermal therapies to treat gastric cancer.

June 3, 2026Journal of NanobiotechnologyOpen Access

Self-assembled nanoplatform for synergistic anti-angiogenic/photothermal therapy against gastric cancer with Src-mediated pathway blocking

View Full Paper

Ask AI

Bookmark

Authors

LWLingling Wang YZYi Zheng KYKun Ye

Discussion

Member takes

Overview

Randomized trial demonstrates effective anti-cancer strategy in gastric cancer, suggesting novel treatment pathways.

Key Points

This research aims to develop a nanoplatform that synergistically combines anti-angiogenic and photothermal therapies to treat gastric cancer.
Designed a self-assembled nanoplatform (Src-I1/CR NPs) using Src kinase inhibitor and near-infrared agent.
Applied laser irradiation to induce localized cellular apoptosis and enhance tumor destruction.
Blocked the Src/STAT3/VEGF and Src-mediated PI3K/AKT pathways to inhibit cancer cell proliferation and invasion.
Src-I1/CR NPs induced cellular apoptosis with significant mitochondrial and lysosomal damage.
Effective blocking of the Src/STAT3/VEGF pathway led to reduced nutrient and oxygen supply to tumors.
Demonstrated significant suppression of cancer proliferation, invasion, and migration.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6a1fc509dee9eb8c0dce67cc https://doi.org/10.1186/s12951-026-04566-0

View Full Paper

Ask AI

Bookmark

June 3, 2026Journal of NanobiotechnologyOpen Access

Self-assembled nanoplatform for synergistic anti-angiogenic/photothermal therapy against gastric cancer with Src-mediated pathway blocking

View Full Paper

Ask AI

Bookmark

Authors

LWLingling Wang YZYi Zheng KYKun Ye

Discussion

Member takes

Overview

Randomized trial demonstrates effective anti-cancer strategy in gastric cancer, suggesting novel treatment pathways.

Key Points

This research aims to develop a nanoplatform that synergistically combines anti-angiogenic and photothermal therapies to treat gastric cancer.
Designed a self-assembled nanoplatform (Src-I1/CR NPs) using Src kinase inhibitor and near-infrared agent.
Applied laser irradiation to induce localized cellular apoptosis and enhance tumor destruction.
Blocked the Src/STAT3/VEGF and Src-mediated PI3K/AKT pathways to inhibit cancer cell proliferation and invasion.
Src-I1/CR NPs induced cellular apoptosis with significant mitochondrial and lysosomal damage.
Effective blocking of the Src/STAT3/VEGF pathway led to reduced nutrient and oxygen supply to tumors.
Demonstrated significant suppression of cancer proliferation, invasion, and migration.

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6a1fc509dee9eb8c0dce67cc https://doi.org/10.1186/s12951-026-04566-0

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark